E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label – The New York Times (Me: without ability to screen who possibly should not risk the shot, they have doomed the vaccine(s) – until the makers can do something to quickly test if ok to take shot)

The EMA declined to name at-risk groups of the population regarding both the AstraZeneca and Johnson & Johnson vaccines, even though most cases reported were among younger women. The agency said it didn’t have sufficient information to draw definitive conclusions.